GENE ONLINE|News &
Opinion
Blog

2021-08-25| InterviewsSpecial

Years After Playing Second Fiddle to CRISPR, RNA Editing Comes Into Its Own – An Interview with Dr. Joshua Rosenthal

by Rajaneesh K. Gopinath
Share To
In recent times, RNA editing has emerged as a technology with a promise to replicate the achievements of gene editing. Eclipsed by the CRISPR frenzy for years, RNA editing is now beginning to draw its deserved recognition.

We interviewed Dr. Joshua Rosenthal who has deeply studied naturally occurring RNA editing phenomenon and has been instrumental in founding an RNA Editing startup.

It's free! Log in now to read

LATEST
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study
2022-09-27
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment
2022-09-26
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!